COMMUNIQUÉS West-GlobeNewswire

Wildflower Featured in NetworkNewsWire Publication Discussing Opportunity in the CBD Rush
01/04/2019
NEW YORK, April 01, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted [...]
5 Companies Prepared to Dominate U.S. Hemp-infused Beverages
01/04/2019
VANCOUVER, British Columbia, April 01, 2019 (GLOBE NEWSWIRE) -- Forecasted to be worth a potential $22 billion by 2022 according to the Brightfield Group, the global hemp CBD market presents one of the most exciting [...]
TG Therapeutics Reports Positive Interim Data from UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the 2019 AACR Annual Meeting
01/04/2019
Overall response rate (ORR) of 52% (N=42), with complete response (CR) rate of 19%, by central independent review committee (IRC) Responses were durable, with median duration of response (DOR) not reached at median 12.5 [...]
The Top 5 Cannabis Retail Brands in Canada
01/04/2019
VANCOUVER, British Columbia, April 01, 2019 (GLOBE NEWSWIRE) -- Cannabis retail has rapidly emerged as one of the most important components of the marijuana value chain. Not only do retail gatekeepers control one of the [...]
Novo Nordisk A/S - Share repurchase programme
01/04/2019
Bagsværd, Denmark, 1 April 2019 - On 1 February 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
ProQR to Present at the H.C. Wainwright Global Life Sciences Conference
01/04/2019
LEIDEN, Netherlands and CAMBRIDGE, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
Merus and Incyte Present MCLA-145 Program Preclinical Data at the AACR Annual Meeting 2019
01/04/2019
CD137 and PD-L1 bispecific antibody with context-dependent T cell activation UTRECHT, Netherlands, April 01, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage [...]
Replimune Announces Presentation at the American Association for Cancer Research Annual Meeting 2019
01/04/2019
WOBURN, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today announced that pre- [...]
Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer
01/04/2019
CAMBRIDGE, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
Tetra Bio-Pharma Announces Employment Contract Renewal of CEO Guy Chamberland
01/04/2019
OTTAWA, April 01, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX-V: TBP) (OTCQB: TBPMF), today announced that the Company has renewed its CEO Guy Chamberland’s employment agreement. “ [...]
Tetra Bio-Pharma annonce le renouvellement du contrat de travail du chef de la direction Guy Chamberland
01/04/2019
OTTAWA, 01 avr. 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (« Tetra » ou la « Société ») (TSX-V : TBP) (OTCQB : TBPMF), a annoncé aujourd’hui que la Société a renouvelé le contrat de travail de son chef de la [...]
Study Confirms Tesamorelin Significantly Reduces Liver Fat in HIV Patients With NAFLD
01/04/2019
MONTREAL, April 01, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that top-line results, from a study funded by the National Institutes of Health led by Dr. Steve [...]
Une étude confirme que la tésamoréline réduit significativement le gras hépatique chez les patients séropositifs atteints de stéatose hépatique non alcoolique
01/04/2019
MONTREAL, 01 avr. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) a annoncé aujourd’hui que les premiers résultats issus d’une étude financée par le National Institutes of Health (NIH), [...]
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
01/04/2019
ZUG, Switzerland and CAMBRIDGE, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/04/2019
DUBLIN, Ireland, April 01, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, today [...]
BioCryst to Present at Upcoming Investor Conferences
01/04/2019
RESEARCH TRIANGLE PARK, N.C., April 01, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the H.C. Wainwright Global Life Sciences Conference in [...]
Emerald’s Pure Sunfarms Joint Venture Acquires Second 1.1 Million Square Foot Greenhouse, Doubling Potential Production Capacity to 150,000 Kilograms
01/04/2019
Emerald extends and expands supply agreement to purchase 25% of Pure Sunfarms’ aggregate cannabis production VANCOUVER, British Columbia, April 01, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald [...]
Algernon Pharmaceuticals Announces Reduction of Key Secondary Marker of Fibrosis in Pre-Clinical NASH Study
01/04/2019
VANCOUVER, British Columbia, April 01, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development [...]
Cyclacel Announces Presentation of Phase 1 Data of Sapacitabine Regimen in Patients With BRCA Mutant Breast Cancer at AACR 2019
01/04/2019
-- Clinical benefit in PARP inhibitor-naïve patients supports ongoing Phase 1b/2 IST study of sapacitabine and olaparib combination in BRCA mutant breast cancer -- BERKELEY HEIGHTS, N.J., April 01, 2019 (GLOBE NEWSWIRE [...]

Pages